热门资讯> 正文
STAAR外科报告第二季度销售额超过9000万美元
2026-07-17 18:21
- STAAR Surgical (STAA) shares fell nearly 12% even as the company reported preliminary second-quarter net sales of more than $90M that topped analysts' estimate of $89.39M and more than doubled from $44.3M a year earlier.
- The company said sales were driven by sequential growth in China, solid gains across the broader Asia-Pacific region, and double-digit percentage growth in the Americas.
- However, sales in the Middle East and parts of Europe, the Middle East and Africa (EMEA), and Asia-Pacific remained under pressure from geopolitical and macroeconomic headwinds. STAAR warned that if those conditions persist or worsen, they could continue to weigh on future sales growth.
More on STAAR Surgical
- STAAR Surgical Company (STAA) Discusses Differentiation of EVO ICL Technology and Market Trends in Refractive Surgery Transcript
- STAAR Surgical Q1 2026: Early Signs Of A Durable Turnaround
- STAAR Surgical Company (STAA) Q1 2026 Earnings Call Transcript
- Wall Street raises STAAR Surgical price target to $40 on Q1 beat: STAA rally analysis
- STAAR Surgical rises on Q1 beat; Wedbush upgrades on China recovery
推荐文章
美股前瞻 | 今晚凌晨两点！贝森特公布对伊”史诗级金融攻势“；拼多多绩后涨逾4%！此前一度跌近5%；存储、光通信盘前齐跌
一图看懂 | 拼多多Q2营收增约8%！经调整净利略超市场预期，研发投入同比大增40%
一图看懂 | 小鹏集团Q2毛利率20.7%超预期！旗下机器人子公司完成9亿美元融资，将正式布局人形机器人赛道
美股盘前 | 存储概念普跌，闪迪跌超4%；阿里巴巴跌超3.5%，宣布800亿港元港股配售；
美扩大国债回购难抑收益率 比特币黄金应声大涨
阿里巴巴融资800亿股价大跌，市场热议港股“二次探底”
阿里重挫10%拖累恒科！港股史上最大配售落地，800亿港元全押AI遭“大空头”开炮，主权基金却逆势抢筹？
沃什若未提供明确指引 美国长债恐遭进一步抛售
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
